Development Level

Tbio 5 | 10,625
Tchem 4 | 1,890

IMPC Phenotype

embryonic lethality prior to t... 1 | 187
enlarged heart 1 | 111

Disease

osteosarcoma 8 | 7,933
Cancer 7 | 2,346
ovarian cancer 5 | 8,491
medulloblastoma, large-cell 4 | 6,234
psoriasis 4 | 6,685
Breast cancer 3 | 3,098
Prostatic Neoplasms 3 | 471
diabetes mellitus 3 | 1,663
glioblastoma 3 | 5,572
group 3 medulloblastoma 3 | 2,254
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
primary Sjogren syndrome 3 | 788
primitive neuroectodermal tumor 3 | 3,031
Alzheimer's disease 2 | 644
Angiomatoid fibrous histiocytoma 2 | 4
Asthma 2 | 349
Cocaine-Related Disorders 2 | 88
Disease Progression 2 | 125
Eye disease 2 | 55
Head and Neck Neoplasms 2 | 23
Heart disease 2 | 279
Kidney disease 2 | 397
Lung disease 2 | 136
Neoplasm Invasiveness 2 | 127
Neoplasm Metastasis 2 | 138
Obesity 2 | 616
Parkinson's disease 2 | 364
Substance Withdrawal Syndrome 2 | 55
Toxic encephalopathy 2 | 131
Vascular disease 2 | 281
atypical teratoid / rhabdoid tumor 2 | 4,369
atypical teratoid/rhabdoid tumor 2 | 1,095
clear cell sarcoma 2 | 6
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 2,514
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
malignant mesothelioma 2 | 3,163
pediatric high grade glioma 2 | 2,712
ulcerative colitis 2 | 2,087
Adenocarcinoma 1 | 115
Adenoid Cystic Carcinoma 1 | 99
Alcohol dependence 1 | 107
Amnestic disorder 1 | 37
Arthritis 1 | 248
Atrophic 1 | 10
Autistic Disorder 1 | 320
Bipolar Disorder 1 | 266
Brain Ischemia 1 | 87
Carcinoma of thyroid 1 | 17
Cardiomyopathies 1 | 90
Cerebrovascular disease 1 | 231
Ceroid lipofuscinosis, neuronal, 6 1 | 7
Cleft palate 1 | 125
Dementia 1 | 129
Duodenal ulcer 1 | 20
Epilepsy 1 | 346
Ewing sarcoma 1 | 27
Female infertility 1 | 28
Gaucher disease type 3 1 | 76
Glioma 1 | 66
Gliosis 1 | 16
Hemolytic anemia 1 | 70
Huntington's disease 1 | 72
Hyperalgesia 1 | 71
Kidney Diseases 1 | 86
Kidney Neoplasm 1 | 27
Liver carcinoma 1 | 217
Liver cell carcinoma 1 | 15
Lung Neoplasms 1 | 171
Major Depressive Disorder 1 | 106
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Morphine dependence 1 | 19
Multiple Sclerosis 1 | 498
Myocardial Infarction 1 | 126
Neoplastic Cell Transformation 1 | 81
Nerve Degeneration 1 | 73
Pancreatitis 1 | 97
Peripheral Neuropathy 1 | 303
Peripheral vascular disease 1 | 90
Polycystic Ovary Syndrome 1 | 334
Polycystic kidney disease 1 | 54
Precancerous Conditions 1 | 69
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 | 18
Pulmonary Fibrosis 1 | 66
Renal Cell Carcinoma 1 | 199
Reperfusion Injury 1 | 84
Rubinstein-Taybi syndrome 1 | 11
Sarcoma 1 | 49
Sepsis 1 | 21
Squamous cell carcinoma 1 | 96
Stomach Neoplasms 1 | 282
Streptococcal pneumonia 1 | 6
Sudden Cardiac Arrest 1 | 16
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
non-small cell lung cancer and chronic obstructive pulmonary disease 1 | 7
ovarian neoplasm 1 | 97
pancreatic carcinoma 1 | 567

Tissue

Blood and immune system 9 | 17,994
Cardiovascular System 9 | 17,957
Digestive Tract 9 | 18,472
Endocrine System 9 | 18,511
Female tissues 9 | 18,646
Liver and Pancreas 9 | 18,135
Male tissues 9 | 17,968
Nervous System 9 | 18,560
Respiratory system 9 | 17,483
Skin and soft tissues 9 | 18,114
Urinary Tract 9 | 18,443

Target Family

Transcription Factor 5 | 1,400
Non-IDG 2 | 11,969
GPCR 1 | 408
Kinase 1 | 634

Grant Application

1R03DK063209-01A1 9 | 9
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Pro-epidermal growth factor EGF Tbio Non-IDG -3.74596 4837.7 851
Transcriptional activator Myb MYB Tbio Transcription Factor -2.96976 925.5 561
POU domain, class 2, transcription factor 1 POU2F1 Tchem Transcription Factor -2.14421 135.4 444
Gastrin-releasing peptide GRP Tbio Non-IDG -3.40446 2732.9 183
Mitogen-activated protein kinase 3 MAPK3 Tchem Kinase -3.62805 3186.8 1232
Cyclic AMP-dependent transcription factor ATF-2 ATF2 Tbio Transcription Factor -2.20613 162.9 1735
Cyclic AMP-responsive element-binding protein 1 CREB1 Tbio Transcription Factor -3.60086 3764.1 1385
Cyclic AMP-dependent transcription factor ATF-1 ATF1 Tchem Transcription Factor -1.72592 50.3 404
Gastrin-releasing peptide receptor GRPR Tchem GPCR -2.39569 248.3 154